These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35576658)

  • 21. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LXR activation causes G1/S arrest through inhibiting SKP2 expression in MIN6 pancreatic beta cells.
    Li Y; Jing C; Tang X; Chen Y; Han X; Zhu Y
    Endocrine; 2016 Sep; 53(3):689-700. PubMed ID: 27071658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Role of Liver X Receptor (LXR)
    Hansmann E; Mennillo E; Yoda E; Verreault M; Barbier O; Chen S; Tukey RH
    Drug Metab Dispos; 2020 Apr; 48(4):255-263. PubMed ID: 31980500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha ) versus liver X receptor.
    Thomas J; Bramlett KS; Montrose C; Foxworthy P; Eacho PI; McCann D; Cao G; Kiefer A; McCowan J; Yu KL; Grese T; Chin WW; Burris TP; Michael LF
    J Biol Chem; 2003 Jan; 278(4):2403-10. PubMed ID: 12441342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and Optimization of a Series of Sulfonamide Inverse Agonists for the Retinoic Acid Receptor-Related Orphan Receptor-α.
    Doebelin C; He Y; Campbell S; Nuhant P; Kumar N; Koenig M; Garcia-Ordonez R; Chang MR; Roush WR; Lin L; Kahn S; Cameron MD; Griffin PR; Solt LA; Kamenecka TM
    Med Chem; 2019; 15(6):676-684. PubMed ID: 30799793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease.
    Fessler MB
    Pharmacol Ther; 2018 Jan; 181():1-12. PubMed ID: 28720427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
    Sato K; Kamada T
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb; 158(2):201-6. PubMed ID: 21056113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.
    Beyer C; Huang J; Beer J; Zhang Y; Palumbo-Zerr K; Zerr P; Distler A; Dees C; Maier C; Munoz L; Krönke G; Uderhardt S; Distler O; Jones S; Rose-John S; Oravecz T; Schett G; Distler JH
    Ann Rheum Dis; 2015 Jun; 74(6):1317-24. PubMed ID: 24618263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver X receptor agonist T0901317 induced liver perturbation in zebrafish: histological, gene set enrichment and expression analyses.
    Sukardi H; Zhang X; Lui EY; Ung CY; Mathavan S; Gong Z; Lam SH
    Biochim Biophys Acta; 2012 Jan; 1820(1):33-43. PubMed ID: 22047996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
    Green CD; Jump DB; Olson LK
    Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha.
    Hu T; Foxworthy P; Siesky A; Ficorilli JV; Gao H; Li S; Christe M; Ryan T; Cao G; Eacho P; Michael MD; Michael LF
    Endocrinology; 2005 Dec; 146(12):5380-7. PubMed ID: 16123164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LXR agonist T0901317 upregulates thrombomodulin expression in glomerular endothelial cells by inhibition of nuclear factor‑κB.
    Ding H; Li Y; Feng Y; Chen J; Zhong X; Wang N; Wang W; Zhang P; Wang L
    Mol Med Rep; 2016 Jun; 13(6):4888-96. PubMed ID: 27082844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
    Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
    Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.
    Zhang-Gandhi CX; Drew PD
    J Neuroimmunol; 2007 Feb; 183(1-2):50-9. PubMed ID: 17175031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
    Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
    Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver X receptor-alpha regulates proopiomelanocortin (POMC) gene transcription in the pituitary.
    Matsumoto S; Hashimoto K; Yamada M; Satoh T; Hirato J; Mori M
    Mol Endocrinol; 2009 Jan; 23(1):47-60. PubMed ID: 19036902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver X receptors (LXR) as therapeutic targets in dyslipidemia.
    Bełtowski J
    Cardiovasc Ther; 2008; 26(4):297-316. PubMed ID: 19035881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver X receptor activator downregulates angiotensin II type 1 receptor expression through dephosphorylation of Sp1.
    Imayama I; Ichiki T; Patton D; Inanaga K; Miyazaki R; Ohtsubo H; Tian Q; Yano K; Sunagawa K
    Hypertension; 2008 Jun; 51(6):1631-6. PubMed ID: 18443233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity.
    Xu J; Wagoner G; Douglas JC; Drew PD
    J Leukoc Biol; 2009 Aug; 86(2):401-9. PubMed ID: 19406833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis.
    Cao G; Liang Y; Broderick CL; Oldham BA; Beyer TP; Schmidt RJ; Zhang Y; Stayrook KR; Suen C; Otto KA; Miller AR; Dai J; Foxworthy P; Gao H; Ryan TP; Jiang XC; Burris TP; Eacho PI; Etgen GJ
    J Biol Chem; 2003 Jan; 278(2):1131-6. PubMed ID: 12414791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.